RecruitingPhase 4NCT07611214
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Sponsor: Aurinia Pharmaceuticals Inc.
Bellaire, TX · Dallas, TX · El Paso, TX · +24 more sites
1 recruiting lupus studies with a site in Lubbock, TX.
Sponsor: Aurinia Pharmaceuticals Inc.
Bellaire, TX · Dallas, TX · El Paso, TX · +24 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.